Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation
Aptevo Therapeutics (NASDAQ:APVO) announced that Peter Pavlik, PhD, Senior Director of Protein Engineering, will chair a session and present at Cambridge Healthcare Institute's Pep Talk conference in January 2025.
The presentation will showcase how Aptevo uses its ADAPTIR and ADAPTIR-FLEX platforms to accelerate cancer therapy development. Dr. Pavlik will demonstrate the company's modular biotherapeutic approach using clinical candidates Mipletamig and ALG.APV-527 as examples.
The company currently has five compounds in clinical and preclinical development and plans to introduce a new molecule in early 2025.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
105271703 : $1 !